DexCom Inc. is set to attend the 85th Scientific Sessions of the American Diabetes Association $(ADA.AU)$ in Chicago. During the event, which will take place on June 21, Dexcom will present extensive clinical data demonstrating the benefits of continuous glucose monitoring (CGM) for individuals living with Type 2 diabetes. Additionally, Grammy-nominated singer and Dexcom Warrior Lance Bass will share his personal experiences with CGM during a panel discussion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.